Turkish Medical Student Journal

Turkish Medical Student Journal

LETTER TO THE EDITOR

Yazarlar: Sevastiani SYRIOTI

Cilt 7 , Sayı 1 , 2020 , Sayfalar 41 - 42

Konular:Tıp

Anahtar Kelimeler:-,--

Özet: Dear editor, In the ‘’Retrospective analysis of chronic myeloid leukemia patients in Trakya University School of Medicine,’’ the authors summarize the use of imatinib which is a tyrosine kinase inhibitor (TKI) in chronic and accelerated phases of the disease as a first-line treatment (1). They stated that the side effects of drugs, insufficient responses, and non-compliances are reasons for switching the drug of choice. I read the article with great interest, paid special attention to the laboratory investigations and physical examinations, thus I would like to underline some points and suggest an alternative perspective to the clinical investigation and treatment options.

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2020, title={LETTER TO THE EDITOR}, volume={7}, number={41–42}, publisher={Turkish Medical Student Journal}, author={Sevastiani SYRIOTI}, year={2020} }
APA
KOPYALA
Sevastiani SYRIOTI. (2020). LETTER TO THE EDITOR (Vol. 7). Vol. 7. Turkish Medical Student Journal.
MLA
KOPYALA
Sevastiani SYRIOTI. LETTER TO THE EDITOR. no. 41–42, Turkish Medical Student Journal, 2020.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri